Testicular cancer is an abnormal, rapid, and invasive growth of cancerous (malignant) cells in the testicles (male sex glands adjacent to the penis).
Although the exact cause of testicular cancer is unknown, several factors seem to increase risk. These include a past medical history of undescended testicle(s), abnormal testicular development, Klinefelter's syndrome (a sex chromosome disorder that may be characterized by low levels of male hormones, sterility, development of breasts, and small testes), or previous testicular cancer. Other factors are under investigation as possible causes. They include exposure to certain chemicals and infection with the human immunodeficiency virus (HIV). A family history of testicular cancer may increase risk. There is no link between vasectomy (an operation to cause sterility) and elevated risk of testicular cancer. Between 6,000 and 8,000 men will be diagnosed with testicular cancers each year. Although testicular cancer accounts for 1% of all cancers in men, it is the most common form of cancer in young men 15 to 40 years old. It may also occur in young boys, but only about 3% of all testicular cancer is found in this group. White American men have about five times the risk of African-American men and more than twice the risk of Asian-American men. The risk for testicular cancer has doubled among white Americans in the past 40 years but has remained the same for African-Americans. The reasons for these differences are not known. Testicular cancers may be classified as follows: Stromal cell tumors are a kind of tumor that is made of Leydig cells (testosterone-secreting cells), Sertoli cells (cells where sperm matures), and granulose cells. These tumors account for only 3-4% of all testicular tumors. However, they do make up nearly 20% of all childhood testicular tumors. These tumors may secrete a hormone -- estradiol -- that can cause one of the symptoms of testicular cancer, gynecomastia (excessive development of breast tissue).
Note: There may be no symptoms.
A physical examination typically reveals a firm, non-tender testicular mass that does not "trans-illuminate" (light from a flashlight held to the scrotum does not pass through the mass). Other tests include: Tissue biopsy is usually by surgical removal of the testicle. After the testicle is removed, the tissue is examined.
|
|
Reviewer Info: Rita Nanda, M.D., Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL. Review provided byVeriMed Healthcare Network.; ADAM Health Illustrated Encyclopedia, 05/26/2006 |